What Happens When You Reach Your Goal Weight on Wegovy

Wegovy lowers body weight by reducing appetite through GLP-1 receptor signalling — when the medicine stops, appetite typically returns to its previous level over weeks to months.
NICE recommends semaglutide for a maximum of two years within a specialist weight management pathway; your prescriber reviews continuation well before that limit.
Weight regain after stopping is the norm, not the exception, trials show most weight returns within one to two years of discontinuation without sustained lifestyle changes.
Maintenance on Wegovy, gradual dose reduction, and lifestyle consolidation are all genuine options, but each carries different implications that only a prescriber can map to your situation.

Reaching your goal weight on Wegovy is a real clinical milestone — and it raises an immediate practical question that many people haven't thought about yet. When you reach goal weight on Wegovy, treatment doesn't simply end. The evidence shows that semaglutide works by continuously suppressing appetite through GLP-1 receptor activity, and that effect stops when the medicine does. For most people, this means goal weight is not the finish line so much as the point where the next conversation with your prescriber becomes urgent. Wegovy is a prescription-only medicine, so what happens next is a clinical decision, not one to make alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The decision you're actually facing at goal weight, and what shapes it

Why reaching goal weight doesn't resolve the treatment question

Think of it this way: the medicine has done the appetite-suppression work, but the biology that made weight gain likely in the first place hasn't changed. GLP-1 receptor agonists like semaglutide address the hormonal signalling around hunger and satiety while you're taking them. That's not a criticism of the medicine, it's how it works, and it works well. The STEP 1 trial, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. What that trial also confirmed, in its withdrawal extension, was that most of that weight returned once semaglutide was stopped.

So when you reach goal weight, you're not choosing between "stay on Wegovy" and "come off Wegovy and everything is fine". You're choosing between a set of genuinely different paths, each with trade-offs. Understanding those trade-offs is what the conversation with your prescriber is for. How Wegovy works throughout treatment can help set that context before you get there.

Continuing treatment at maintenance: what the evidence says

Staying on Wegovy at a lower or maintenance dose while consolidating lifestyle habits is one option your prescriber may discuss. There's a reasonable rationale: the medicine keeps appetite suppression in place while you build sustainable eating and activity patterns. The practical complication is the NICE recommendation. NICE's appraisal of semaglutide for weight management (TA875) recommends use for a maximum of two years within a specialist weight management service, so open-ended continuation isn't the standard NHS pathway, though private prescribing follows clinical judgement alongside the licensed use.

Private treatment through a regulated pharmacy like ours means your prescriber reviews your situation before every repeat order, every time, not just at the two-year mark. If you're approaching goal weight and wondering about cost over a longer maintenance period, our Wegovy cost page lays out what's included in private treatment pricing.

One thing worth saying plainly: if you order by 12pm on a weekday (say, the Monday after payday, which is when a lot of repeat requests come through) dispatch happens the same day once clinical review is complete. The timing matters because a break in treatment, even a short one, can affect how quickly your appetite shifts.

What happens when you stop: the rebound reality

This is the part that catches people off guard. If you want to understand what happens when you stop taking Wegovy, the short answer is that most clinical evidence (including data from the semaglutide withdrawal studies) shows appetite returning significantly within weeks, with weight regain following over the subsequent months. That's not failure; it's the predictable consequence of removing a medicine that was actively doing a hormonal job.

The distinction that matters at goal weight is between stopping abruptly, tapering gradually under prescriber guidance, or transitioning to a different strategy. None of these are decisions to take based on the fact that the scales have reached a number. A prescriber needs to know your weight trajectory over time, your current dose, and what lifestyle habits are genuinely in place. The full picture of what stopping means for weight loss specifically covers this in more detail.

If you've been considering other weight-loss treatment options, goal weight is also a natural point to ask your prescriber whether any adjustment to your approach makes sense.

How to plan this conversation with your prescriber

The most useful thing you can do before reaching goal weight is raise the question early, not the day the scales hit the target. A question our prescribers hear regularly in aftercare check-ins is: "When do I stop, and what happens next?" The honest answer is that it varies by person, and any prescriber giving a one-size answer isn't giving a clinical one.

What a prescriber will want to consider: how long you've been at the maintenance dose, whether the weight loss has plateaued or is still gradual, what weight-related health conditions you started with and where they now stand, and whether you have a realistic picture of your eating and activity post-treatment. Getting off Wegovy safely and with the least risk of rebound is a process, not an event. The general FAQs cover common questions about Wegovy treatment if you want background before your review.

Pregnancy, breastfeeding, and trying to conceive are all reasons why a prescriber would recommend stopping semaglutide; the same applies to any significant change in health status. These are clinical decisions the prescriber makes with you, not administrative ones.

If you're reaching goal weight and want a clinical review of your next steps, our prescribers are available seven days a week. Speak to our prescribers through a free consultation to talk through what makes sense for your situation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions